VANGUARD GROUP INC

Holdings History for Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN)

Symbol: LTRN on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$1,163,644	384,041	0		$3.03	Q4 2025
30 Sep 2025	0%	+0%	$1,670,578	384,041	+20,321	+5.6%	$4.35	Q3 2025
30 Jun 2025	0%	0%	$1,149,355	363,720	0		$3.16	Q2 2025
31 Mar 2025	0%	0%	$1,287,569	363,720	0		$3.54	Q1 2025
31 Dec 2024	0%	0%	$1,160,266	363,720	0		$3.19	Q4 2024
30 Sep 2024	0%	0%	$1,334,853	363,720	0		$3.67	Q3 2024
30 Jun 2024	0%	0%	$1,698,573	363,720	0		$4.67	Q2 2024
31 Mar 2024	0%	0%	$3,200,736	363,720	-1,614	-0.44%	$8.80	Q1 2024
31 Dec 2023	0%	0%	$1,563,629	365,334	-2,120	-0.58%	$4.28	Q4 2023
30 Sep 2023	0%	0%	$1,253,019	367,454	0		$3.41	Q3 2023
30 Jun 2023	0%	0%	$2,072,440	367,454	0		$5.64	Q2 2023
31 Mar 2023	0%	0%	$1,774,803	367,454	0		$4.83	Q1 2023
31 Dec 2022	0%	0%	$2,219,422	367,454	+135	+0.04%	$6.04	Q4 2022
30 Sep 2022	0%	0%	$1,756,000	367,319	0		$4.78	Q3 2022
30 Jun 2022	0%	0%	$2,097,000	367,319	0		$5.71	Q2 2022
31 Mar 2022	0%	0%	$2,626,000	367,319	-1,385	-0.38%	$7.15	Q1 2022
31 Dec 2021	0%	+0%	$2,942,000	368,704	+97,884	+36%	$7.98	Q4 2021
30 Sep 2021	0%	0%	$3,027,000	270,820	+1,391	+0.52%	$11.18	Q3 2021
30 Jun 2021	0%	+0%	$3,933,000	269,429	+10,282	+4%	$14.60	Q2 2021
31 Mar 2021	0%	+0%	$4,701,000	259,147	+259,147	NEW	$18.14	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.